{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:26:31Z","timestamp":1790785591310,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Left ventricular hypertrophy (LVH) is often a complication of hypertension and an independent risk factor for cardiovascular events. In Ethiopia, there is a scarcity of data on the prevalence and associated factors of left ventricular hypertrophy among hypertensive adults. This study aimed to assess the prevalence and associated factors of left ventricular hypertrophy among adult patients with hypertension attending treatment at two public hospitals in Harar, Eastern Ethiopia from 20 December 2021 to 20 December 2023.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A hospital-based cross-sectional study was conducted on 264 hypertensive patients from 20 December 2021 to 20 December 2023. A pretested structured questionnaire and checklist were used to collect data from participants and their clinical records. The data were collected by trained residents and interns. Data were analyzed using SPSS version 29. Left ventricular mass was measured by transthoracic echocardiography. Associations between categorical variables were assessed using a chi-square test and odds ratio with 95% confidence interval. A logistic regression model was used to identify risk factors of LVH. <jats:italic>p<\/jats:italic>-values of &amp;lt;0.05 were considered as statistically significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 264 adults with hypertension, with a mean age of 58.4 years, and the majority (54.5%) were male. The prevalence of echocardiographically confirmed left ventricular hypertrophy (LVH) was 30.7% (95% CI: 25.1%\u201336.3%), with mild LVH being the most common type (51%). Significant predictors of LVH included age over 60 years [adjusted odds ratio (AOR)\u2009=\u20095.981, CI\u2009=\u20091.832\u201319.522, <jats:italic>p<\/jats:italic>\u2009=\u20090.003], khat chewing (AOR\u2009=\u20092.676, CI\u2009=\u20091.786\u20139.109, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), diabetes (AOR\u2009=\u200910.430, CI\u2009=\u20092.904\u201337.454, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), poor medication adherence (AOR\u2009=\u20094.132, CI\u2009=\u20091.208\u201314.141, <jats:italic>p<\/jats:italic>\u2009=\u20090.024), uncontrolled systolic blood pressure (AOR\u2009=\u20098.340, CI\u2009=\u20092.280\u201330.512, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), lack of home blood pressure monitoring (AOR\u2009=\u20095.591, CI\u2009=\u20091.041\u201330.012, <jats:italic>p<\/jats:italic>\u2009=\u20090.045), and longer hypertension duration (AOR\u2009=\u20098.766, CI\u2009=\u20092.101\u201336.584, <jats:italic>p<\/jats:italic>\u2009=\u20090.003). These findings emphasize the need to address modifiable risk factors in managing hypertension to reduce the burden of LVH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The echocardiographic prevalence of LVH was 30.7% in the study population. These results highlight the importance of addressing modifiable risks to reduce LVH burden.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1533707","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:23:21Z","timestamp":1744867401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Understanding the hidden burden: prevalence and factors linked to left ventricular hypertrophy in hypertensive patients receiving care in Harari region, Ethiopia"],"prefix":"10.3389","volume":"12","author":[{"given":"Ashenafi","family":"Tadesse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerihun Abera","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megnot Hailu","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinetibeb","family":"Mesfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"B2","article-title":"WHO Guideline for the pharmacological treatment of hypertension in adults","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12889-020-8386-5","article-title":"Prevalence and associated factors of hypertension among adults in Gadarif in Eastern Sudan: a community-based study","volume":"20","author":"Omar","year":"2020","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/IBPC.S150628","article-title":"Blood pressure control status and associated factors among adult hypertensive patients on outpatient follow-up at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow-up study","volume":"11","author":"Animut","year":"2018","journal-title":"Integr Blood Press Control"},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40985-015-0014-z","article-title":"Prevalence of hypertension in Ethiopia: a systematic meta-analysis","volume":"36","author":"Kibret","year":"2015","journal-title":"Public Health Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2637051","DOI":"10.1155\/2017\/2637051","article-title":"Target organ damage and the long term effect of nonadherence to clinical practice guidelines in patients with hypertension: a retrospective cohort study","volume":"2017","author":"Abegaz","year":"2017","journal-title":"Int J Hypertens"},{"key":"B7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/IBPC.S276089","article-title":"Epidemiology of hypertension in Ethiopia: a systematic review","volume":"13","author":"Legese","year":"2020","journal-title":"Integr Blood Press Control"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pcad.2019.11.009","article-title":"Left ventricular hypertrophy and hypertension","volume":"63","author":"Yildiz","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-020-1017-9","article-title":"Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy","volume":"22","author":"Nwabuo","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/ajh\/hpab037","article-title":"Concentric vs. Eccentric left ventricular hypertrophy: does it matter? It is all \u201cblood pressure centered\u201d","volume":"34","author":"Iyengar","year":"2021","journal-title":"Am J Hypertens"},{"key":"B11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-4614-5203-4_8","article-title":"Differences in concentric cardiac hypertrophy and eccentric hypertrophy","volume":"4","author":"M\u00fcller","year":"2013","journal-title":"Cardiac Adapt Mol Mech"},{"key":"B12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1519\/jsc.0000000000003086","article-title":"Comparison of the effects of eccentric, concentric, and eccentric-concentric isotonic resistance training at two velocities on strength and muscle hypertrophy","volume":"34","author":"\u00dcnl\u00fc","year":"2020","journal-title":"J Strength Cond Res"},{"key":"B13","volume-title":"Prevalence of Left Ventricular Hypertrophy by Echocardiography and Utility of ECG Voltage Criteria for Left Ventricular Hypertrophy among Ambulatory Hypertensive Patients at Mbagathi Hospital","author":"Ndiritu","year":"2017"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e12880","DOI":"10.1111\/anec.12880","article-title":"The association between ECG criteria and Echo criteria for left ventricular hypertrophy in a general Chinese population","volume":"26","author":"Lv","year":"2021","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5348\/C03-2018-8-OA","article-title":"Left ventricular hypertrophy in hypertensive patients: prevalence and diagnosis","volume":"4","author":"Khaznadar","year":"2018","journal-title":"Edorium J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s43044-023-00396-9","article-title":"Left ventricular noncompaction in Ibadan, Nigeria","volume":"75","author":"Ogah","year":"2023","journal-title":"Egypt Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1002\/hsr2.25","article-title":"Left ventricular mass estimation by different partition values in a large population of black hypertensive subjects","volume":"1","author":"Ojji","year":"2018","journal-title":"Health Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-7-45","article-title":"Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors","volume":"7","author":"Jaleta","year":"2014","journal-title":"BMC Res Notes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3986-1","article-title":"Prevalence and associated factors of hypertension among adult patients in Felege-Hiwot Comprehensive Referral Hospitals, Northwest, Ethiopia: a cross-sectional study","volume":"11","author":"Belachew","year":"2018","journal-title":"BMC Res Notes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8020129","DOI":"10.1155\/2020\/8020129","article-title":"The prevalence and associated factors of hypertension among adults in southern Ethiopia","volume":"2020","author":"Kebede","year":"2020","journal-title":"Int J Chronic Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40119-022-00260-y","article-title":"Left ventricular hypertrophy: etiology-based therapeutic options","volume":"11","author":"Sayin","year":"2022","journal-title":"Cardiol Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e17550","DOI":"10.7759\/cureus.17550","article-title":"Correlation of coronary artery disease and left ventricular hypertrophy","volume":"13","author":"Khalid","year":"2021","journal-title":"Cureus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41371-021-00503-w","article-title":"Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans?","volume":"35","author":"Nadarajah","year":"2021","journal-title":"J Hum Hypertens"},{"key":"B24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1082008","DOI":"10.3389\/fcvm.2022.1082008","article-title":"Prognostic implication of left ventricular hypertrophy regression after antihypertensive therapy in patients with hypertension","volume":"9","author":"Kim","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B26","article-title":"Hypertension, left ventricular hypertrophy, and heart failure","volume":"6","author":"Corbett","year":"2020","journal-title":"Hypertension"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1111\/jch.14047","article-title":"Comparative efficacy of different types of antihypertensive drugs in reversing left ventricular hypertrophy as determined with echocardiography in hypertensive patients: a network meta-analysis of randomized controlled trials","volume":"22","author":"Chen","year":"2020","journal-title":"J Clin Hypertens"},{"key":"B28","first-page":"35","volume-title":"Health Management Information System (HMIS) \/ Monitoring and Evaluation (M&E)","year":"2022"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/hypertensionaha.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-8363-z","article-title":"Burden of prehypertension among adults in Kenya: a retrospective analysis of findings from the Healthy Heart Africa (HHA) programme","volume":"20","author":"Mecha","year":"2020","journal-title":"BMC Public Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.echo.2018.10.006","article-title":"Need for a global definition of normative echo values\u2014rationale and design of the world alliance of societies of echocardiography normal values study (WASE)","volume":"32","author":"Asch","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/ehjci\/jev076","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)","volume":"16","author":"Marwick","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/02701367.2020.1788699","article-title":"Adherence factors related to exercise prescriptions in healthcare settings: a review of the scientific literature","volume":"93","author":"Calonge Pascual","year":"2022","journal-title":"Res Q Exerc Sport"},{"key":"B34","volume-title":"Comorbidity Versus Multimorbidity: Why it Matters","author":"Harrison","year":"2021"},{"key":"B35","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow","year":"2010","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/1090198115577376","article-title":"Disparities in the population distribution of African American and non-Hispanic white smokers along the quitting continuum","volume":"42","author":"Trinidad","year":"2015","journal-title":"Health Educ Behav"},{"key":"B37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12872-023-03452-z","article-title":"Association between weight-adjusted-waist index and risk of cardiovascular diseases in United States adults: a cross-sectional study","volume":"23","author":"Fang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-018-0888-z","article-title":"Non-adherence to antihypertensive pharmacotherapy in Buea, Cameroon: a cross-sectional community-based study","volume":"18","author":"Adidja","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"B39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12877-023-03768-7","article-title":"Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Geriatr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-017-0201-0","article-title":"Availability of adequately iodized in northwest Ethiopia: a cross-sectional study","volume":"75","author":"Abebe","year":"2017","journal-title":"Arch Public Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e12067","DOI":"10.1097\/MD.0000000000012067","article-title":"Impact of left ventricular hypertrophy on long-term clinical outcomes in hypertensive patients who underwent successful percutaneous coronary intervention with drug-eluting stents","volume":"97","author":"Kim","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25259\/ANMRP_1_2022","article-title":"Prevalence of echocardiographic left ventricular hypertrophy among hypertensives in a tertiary health institution in Nigeria","volume":"3","author":"Ngabea","year":"2022","journal-title":"ANMRP"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2261-14-136","article-title":"Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/ijgm.s273668","article-title":"Blood pressure control, left ventricular hypertrophy and treatment practice among hypertensive patients in Ethiopia","volume":"13","author":"Kinfe","year":"2020","journal-title":"Int J Gen Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010228","article-title":"Prevalence and characterisation of severe left ventricular hypertrophy diagnosed by echocardiography in hypertensive patients","volume":"12","author":"Apitz","year":"2022","journal-title":"J Clin Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.25176\/RFMH.v21i1.3270","article-title":"Factors related to left ventricular hypertrophy in adult persons living at altitude","volume":"21","author":"Valentin Diaz Lazo","year":"2021","journal-title":"Revista de la Facultad de Medicina Humana"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e028219","DOI":"10.1161\/jaha.122.028219","article-title":"Relationship between left ventricular hypertrophy and diabetes is likely bidirectional: a temporality analysis","volume":"12","author":"Lv","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes Mellitus and left ventricular hypertrophy in a multi-ethnic population","volume":"101","author":"Eguchi","year":"2018","journal-title":"Am J Cardiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1038\/s41598-021-86693-2","article-title":"Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, central Thailand","volume":"11","author":"Viwatrangkul","year":"2021","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/jch.13991","article-title":"Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography","volume":"22","author":"Pedersen","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4236\/wjcd.2018.812056","article-title":"Left ventricular hypertrophy and predictive factors among Congolese hypertensive patients","volume":"8","author":"Ikama","year":"2018","journal-title":"World J Cardiovasc Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1136\/hrt.72.3_suppl.s24","article-title":"Role of ACE inhibitors in hypertension with left ventricular hypertrophy","volume":"72","author":"Richards","year":"2004","journal-title":"Br Heart J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"107680778-10778","DOI":"10.21037\/apm-21-2455","article-title":"Effect of amlodipine on ventricular hypertrophy in hypertension patients: a systematic review and meta-analysis","volume":"10","author":"Gao","year":"2021","journal-title":"Ann Palliat Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1533707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:23:22Z","timestamp":1744867402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1533707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":53,"alternative-id":["10.3389\/fcvm.2025.1533707"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1533707","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"article-number":"1533707"}}